UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 168

Sortiert nach

Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab

Current topics in microbiology and immunology, 2008, Vol.317, p.103

2008

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

Infection and immunity, 2001-06, Vol.69 (6), p.3581-3590

2001

Link zum Volltext

Verfügbarkeit prüfen

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

Clinical immunology (Orlando, Fla.), 2003-09, Vol.108 (3), p.241-247

2003

Link zum Volltext

Verfügbarkeit prüfen

Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans

Infection and Immunity, 1997-02, Vol.65 (2), p.452-456

1997

Link zum Volltext

Verfügbarkeit prüfen

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

Pediatrics (Evanston), 2000-01, Vol.105 (1), p.e12

2000

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults

Infection and immunity, 2001-02, Vol.69 (2), p.988-995

2001

Link zum Volltext

Verfügbarkeit prüfen

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults

Gastroenterology (New York, N.Y. 1943), 1999-04, Vol.116 (4), p.804-812

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of Small Bowel Bacterial Overgrowth on the Immunogenicity of Single-Dose Live Oral Cholera Vaccine CVD 103-HgR

The Journal of infectious diseases, 1999-11, Vol.180 (5), p.1709-1712

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. Volunteers

Infection and immunity, 2000-03, Vol.68 (3), p.1196-1201

2000

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization

Pediatrics (Evanston), 1999-02, Vol.103 (2), p.E14

1999

Link zum Volltext

Verfügbarkeit prüfen

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans

Infection and immunity, 2000-03, Vol.68 (3), p.1034-1039

2000

Link zum Volltext

Verfügbarkeit prüfen

Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG

Infection and Immunity, 1996-11, Vol.64 (11), p.4542-4548

1996

Link zum Volltext

Verfügbarkeit prüfen

Phase I Evaluation of ΔvirG Shigella sonnei Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy Adults

Infection and Immunity, 2002-04, Vol.70 (4), p.2016-2021

2002

Link zum Volltext

Verfügbarkeit prüfen

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens

Vaccine, 1997-04, Vol.15 (6), p.700-708

1997

Link zum Volltext

Verfügbarkeit prüfen

A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali

Bulletin of the World Health Organization, 1998, Vol.76 (1), p.63-71

1998

Link zum Volltext

Verfügbarkeit prüfen

Attenuated Shigella flexneri 2a ΔguaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection

Infection and immunity, 2001-05, Vol.69 (5), p.3150-3158

2001

Link zum Volltext

Verfügbarkeit prüfen

Attenuated Shigella flexneri 2a Vaccine Strain CVD 1204 Expressing Colonization Factor Antigen I and Mutant Heat-Labile Enterotoxin of Enterotoxigenic Escherichia coli

Infection and Immunity, 2000-09, Vol.68 (9), p.4884-4892

2000

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

Infection and Immunity, 1997-08, Vol.65 (8), p.3381-3385

1997

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Volunteer Model of Cholera with Frozen Bacteria as the Challenge

Infection and Immunity, 1998-05, Vol.66 (5), p.1968-1972

1998

Link zum Volltext

Verfügbarkeit prüfen

Vibrio cholerae O1 Can Assume a Chlorine-Resistant Rugose Survival Form That Is Virulent for Humans

The Journal of infectious diseases, 1996-12, Vol.174 (6), p.1364-1368

1996

Link zum Volltext

Verfügbarkeit prüfen

Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens

The Lancet (British edition), 1998-05, Vol.351 (9114), p.1472-1476

1998

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera

Infection and Immunity, 1996-01, Vol.64 (1), p.10-15

1996

Link zum Volltext

Verfügbarkeit prüfen

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity

Vaccine, 1995, Vol.13 (16), p.1488-1494

1995

Link zum Volltext

Verfügbarkeit prüfen

Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans

The Journal of experimental medicine, 1988-10, Vol.168 (4), p.1487-1492

1988

Link zum Volltext

Verfügbarkeit prüfen

Experimental human infections with Giardia lamblia

The Journal of infectious diseases, 1987-12, Vol.156 (6), p.974

1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(167)
magazinearticle
(1)

Sprache

Englisch
(167)
Japanisch
(15)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(132)
Science & Technology
(118)
Life Sciences & Biomedicine
(114)
Biological And Medical Sciences
(111)
Infectious Diseases
(97)
Immunology
(84)
Microbiology
(78)
Adult
(63)
Fundamental And Applied Biological Sciences. Psychology
(62)
Medical Sciences
(52)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(52)
Bacteriology
(47)
Animals
(43)
Female
(39)
Vaccination
(38)
Administration, Oral
(37)
Antibodies, Bacterial - Blood
(37)
Male
(34)
Vaccines, Attenuated - Immunology
(34)
Double-Blind Method
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults

Effect of Small Bowel Bacterial Overgrowth on the Immunogenicity of Single-Dose Live Oral Cholera Vaccine CVD 103-HgR

Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. Volunteers

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans

Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG

Phase I Evaluation of ΔvirG Shigella sonnei Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy Adults

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens

A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali

Attenuated Shigella flexneri 2a ΔguaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection

Attenuated Shigella flexneri 2a Vaccine Strain CVD 1204 Expressing Colonization Factor Antigen I and Mutant Heat-Labile Enterotoxin of Enterotoxigenic Escherichia coli

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

Validation of a Volunteer Model of Cholera with Frozen Bacteria as the Challenge

Vibrio cholerae O1 Can Assume a Chlorine-Resistant Rugose Survival Form That Is Virulent for Humans

Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens

Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity

Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans

Experimental human infections with Giardia lamblia

Suchergebnisse filtern